overall objective proposal elucidate signaling mechanisms responsible adaptive response heart ischemic pharmacologic stimuli attempt develop unifying signal transduction paradigm applicable three different forms preconditioning pc early phase ischemic pc late phase ischemic pc noinduced pharmacologic pc fundamental hypothesis three cases activation pkcepsilon subsequent recruitment srclck play essential mechanistic role propose pkcepsilonsrclck signaling pathway induces late pc upregulating inos transcriptional level day 1 posttranslational level day 2 broad multidisciplinary approach used combine diverse techniques integrative physiology protein chemistry mass spectrometry cellular biology molecular biology gene targeting transgenesis integrate genetic information molecular level biochemical information protein structure level physiologic information whole animal level unequivocal evidence essential role pkcepsilon src lck pc provided use two novel pkcepsilon transgenic mouse lines constitutively active dominant negative mutants pkcepsilon src lck knockout mice wellestablished murine model pc enable us examine kinase specific modulation pkcepsilon src lck intact animal role pkcepsilon ischemic pc noinduced pc conclusively established determining effects specific transgenic activation inhibition isozyme cardioprotection activity protein content seven src ptks expressed mouse heart fyn fgr yes src lyn lck blk systematically measured serial times ischemic pc donor administration role src ptks triggering versus mediating late pc discerned comparing inhibition kinases day 1 versus day 2 targeted disruption src lck gene employed conclusively establish specific function individual ptks pc protection hierarchical positions pkcepsilon srclck signaling cascade pc identified determining whether specific transgenic activation pkcepsilon leads activation srclck srclckdependent protection conversely whether specific transgenic inhibition pkcepsilon blocks activation srclck concomitant protection induced pc downstream targets pkcepsilonsrclck pathway explored analyzing signaling elements known govern nfkappab activity nik mekk1 ikkalpha ikkbeta ikappabalpha absence presence targeted src lck gene ablation finally role src ptks posttranslational modulation inos day 2 elucidated measuring inos activity tyrosine phosphorylation absence presence src ptk inhibitors proposal provide important new insights molecular mechanisms ischemic pc pharmacologic pc role pkcepsilon srclck cardiac signaling general elucidation mechanism pc facilitate development novel therapeutic strategies duplicate powerful cardioprotective effects